Telix Pharmaceuticals Lim...

NASDAQ: TLX · Real-Time Price · USD
16.07
-0.43 (-2.61%)
At close: Jul 03, 2025, 3:50 PM
16.24
1.06%
After-hours: Jul 03, 2025, 03:50 PM EDT
-2.61%
Bid 16
Market Cap 5.44B
Revenue (ttm) 24.45M
Net Income (ttm) -1.98M
EPS (ttm) 0.09
PE Ratio (ttm) 178.56
Forward PE n/a
Analyst Buy
Ask 16.62
Volume 31,814
Avg. Volume (20D) 30,791
Open 16.10
Previous Close 16.50
Day's Range 15.90 - 16.29
52-Week Range 13.61 - 30.36
Beta 2.41

About TLX

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TLX
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for TLX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
4 months ago
+12%
Telix Pharmaceuticals shares are trading higher af... Unlock content with Pro Subscription
5 months ago
+1.07%
Telix Pharmaceuticals shares are trading higher after the company announced it will buy the therapeutic pipeline, technology platform, and research facility from ImaginAb.